Point72 Asia (Singapore)’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$42.2K	Buy	+29,070	New	+$42.2K	0.01%	625
2024 Q2	–	Sell	-19,736	Closed	-$157K	–	1479
2024 Q1	$157K	Buy	+19,736	New	+$157K	0.04%	515